Most U.S. drugs rely on ingredients from China, raising safety, quality, and national security concerns. Experts call for ...

The global market for vitamin D ingredients is expected to grow at a CAGR of 7.2% between 2025 and 2035, reaching USD 3.2 ...

Gen Z's preference for convenient formats like gummies and effervescent powders, coupled with rising health awareness, is ...

Earlier diagnoses and advancements in treatment options are providing hope for patients with endometrial cancer like Yaca.

Rising prevalence of chronic diseases worldwide & rising health consciousness among people are projected to drive the nutritional food and ...

The global vitamin D therapy market was valued at approximately USD 4.59 billion in 2022 and is projected to grow at an impressive growth rate of around 11.6% over the forecast period from 2023 to ...

The Business Research Company The Business Research Company's Personalized Daily Vitamin Packs Global Market Report 2025 – Market Size, Tre ...

Police sources say it happened at the Baychester Station near East 180th Street and Eastchester-Dyer Avenue.

Per the terms of the deal, GSK will pay $1.2 billion as an upfront payment to Boston Pharma. The Massachusetts-based company will also be eligible to receive up to $800 million in potential ...

(Reuters) -British pharmaceutical giant GlaxoSmithKline and rival Pfizer have agreed to end a lawsuit that alleged Pfizer's respiratory syncytial virus (RSV) vaccine Abrysvo violated GSK's patent ...

Background Public Health England advises 400 IU/day vitamin D supplementation for children over 1 year. Commercially available children’s multivitamin and vitamin D supplements were surveyed to ...

Such factors include, but are not limited to, those described under Item 3.D “Risk factors” in GSK’s Annual Report on Form 20-F for 2023, and GSK’s Q3 Results for 2024.